⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15492610 | 0.61 | — | — | |
| SCHEMBL11918101 | 0.61 | — | — | |
| SCHEMBL16263257 | 0.57 | — | — | |
| SCHEMBL9624492 | 0.56 | — | — | |
| SCHEMBL14572471 | 0.56 | — | — | |
| SCHEMBL821947 | 0.56 | — | — | |
| SCHEMBL4364766 | 0.56 | — | — | |
| SCHEMBL23101768 | 0.56 | — | — | |
| SCHEMBL24388710 | 0.56 | — | — | |
| SCHEMBL16129114 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014096965-A2 | NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS | RVX THERAPEUTICS INC. (CA) | 2014-06-26 | — | — | WO | disclosed |